marketinsider

Uh-Oh, Fate Alert: Monsey Law Firm on the Case of Wohl & Fruchter LLP Investigating Possible Securities Claims Against Fate Therapeutics Inc.

Welcome to the Wild World of Securities Investigations What Happened in Monsey? It was a typical day in Monsey, N.Y., when the news broke – the law firm of Wohl & Fruchter LLP is investigating whether Fate Therapeutics, Inc. (Nasdaq: FATE) violated federal securities laws. Specifically, they’re looking into the sudden termination of Fate’s collaboration…

Read More

Important Deadline Approaching: Respected Investor Counsel Urges Silvergate Capital Corporation Investors with Losses over $100K to Seek Legal Guidance in Securities Class Action Lawsuit

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Silvergate Capital Corporation Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – SI NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — Investing in the stock market can be a risky endeavor, and investors must always be vigilant about protecting their rights and interests….

Read More

Attention NewAge Inc. Investors: Protect Your Losses Over $100K Before the Deadline – Investor Counsel Rosen Urges Action in First Securities Class Action

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages NewAge Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline Overview ROSEN Law Firm, a global investor rights law firm, wants to remind investors of NewAge, Inc. about the upcoming deadline for the securities purchased between January 18, 2018, and October 18, 2022. The lead plaintiff deadline…

Read More

Oops, Did the Bahamas Regulator Just Call Out FTX CEO for Playing Fast and Loose with Customer Funds?

Defending the Securities Commission of The Bahamas: A Closer Look at the Recent Controversy Setting the Record Straight The Securities Commission of The Bahamas (SCB) recently found itself in the spotlight following a statement released to counter “material misstatements” made by John Ray, the newly appointed Chief Executive of FTX. Ray, who is overseeing the…

Read More

Merger Madness: Brookline Bancorp Inc. Spills the Tea on Preliminary Results of PCSB Financial Corporation Union!

Boston, Dec. 30, 2022 (GLOBE NEWSWIRE) – Brookline Bancorp, Inc. Announces Preliminary Results of Merger Consideration Elections Regarding Pending PCSB Financial Corporation Acquisition Exciting news in the financial industry! Brookline Bancorp, Inc. (NASDAQ: BRKL) has just released the preliminary results of the elections surrounding the merger consideration for the pending acquisition of PCSB Financial Corporation…

Read More

Attention Investors: Don’t Be a Fig-ure of Loss! Secure Counsel Before the January 3rd Deadline with Rosen, the Investor Rights Superhero Firm

Investor Rights Law Firm Reminds FIGS, Inc. Investors of Final Deadline Alert Why You Should Pay Attention Imagine this: you’re a savvy investor, always on the lookout for the next big thing in the stock market. You come across FIGS, Inc., a company that promises to revolutionize the world of healthcare apparel. Intrigued, you decide…

Read More

Unlocking the Power of Point-of-Purchase Packaging: How Surging Demand for Consumer Goods is Driving Growth – A Fact MR Report

Surging Demand for Consumer Goods to Increase Usage of Point-of-Purchase Packaging Solutions Recent Study Reveals Growing Trend Recently published Fact.MR’s report reveals that the growing use of personal care products will fuel worldwide demand for point-of-purchase packaging solutions. This insight comes at a time when the consumer goods industry is booming, with more and more…

Read More

Breaking Boundaries: Nexcella Inc., a Subsidiary of Immix Biopharma, to Showcase at Prestigious European Medical Conference

Breaking Boundaries: Nexcella Inc., a Subsidiary of Immix Biopharma, to Showcase at Prestigious European Medical Conference Updated clinical data for NXC-201, a next-generation CAR-T for multiple myeloma and AL amyloidosis, will be presented in Rotterdam, Netherlands February 9-11, 2023 LOS ANGELES, CA, Dec. 28, 2022 (GLOBE NEWSWIRE) — Nexcella, Inc., a subsidiary of Immix Biopharma,…

Read More